Review Articles


The EMT spectrum and therapeutic opportunities
Dominic C. Voon, Ruby Y. Huang, Rebecca A. Jackson, Jean P. Thiery
Volume 11, Issue 7, July 2017

EMT- and MET-related processes in nonepithelial tumors: importance for disease progression, prognosis, and therapeutic opportunities
Ulf D. Kahlert, Justin V. Joseph, Frank A. E. Kruyt
Volume 11, Issue 7, July 2017

Epithelial-to-mesenchymal transition transcription factors in cancer-associated fibroblasts
Josep Baulida
Volume 11, Issue 7, July 2017

New insights into the role of EMT in tumor immune escape
Stéphane Terry, Pierre Savagner, Sandra Ortiz‐Cuaran, Linda Mahjoubi, Pierre Saintigny, Jean‐Paul Thiery, Salem Chouaib
Volume 11, Issue 7, July 2017

EMT and inflammation: inseparable actors of cancer progression
Meggy Suarez‐Carmona, Julien Lesage, Didier Cataldo, Christine Gilles
Volume 11, Issue 7, July 2017

Revisiting epithelial-mesenchymal transition in cancer metastasis: the connection between epithelial plasticity and stemness
Tsai‐Tsen Liao, Muh‐Hwa Yang
Volume 11, Issue 7, July 2017

Epithelial-mesenchymal transition in cancer metastasis through the lymphatic system
Mikael C. Karlsson, Santiago F. Gonzalez, Josefin Welin, Jonas Fuxe
Volume 11, Issue 7, July 2017

Cancer metastasis through the prism of epithelial-to-mesenchymal transition in circulating tumor cells
Douglas S. Micalizzi, Daniel A. Haber, Shyamala Maheswaran
Volume 11, Issue 7, July 2017

EMT and MET: necessary or permissive for metastasis?
Mohit Kumar Jolly, Kathryn E. Ware, Shivee Gilja, Jason A. Somarelli, Herbert Levine
Volume 11, Issue 7, July 2017

Epithelial/mesenchymal plasticity: how have quantitative mathematical models helped improve our understanding?
Mohit Kumar Jolly, Satyendra C. Tripathi, Jason A. Somarelli, Samir M. Hanash, Herbert Levine
Volume 11, Issue 7, July 2017

EMT: Present and future in clinical oncology
Patricia G. Santamaria, Gema Moreno‐Bueno, Francisco Portillo, Amparo Cano
Volume 11, Issue 7, July 2017

Determinants of metastatic competency in colorectal cancer
Daniele V. F. Tauriello, Alexandre Calon, Enza Lonardo, Eduard Batlle
Volume 11, Issue 1, January 2017

Epigenetic determinants of metastasis
Saroor A. Patel, Sakari Vanharanta
Volume 11, Issue 1, January 2017

Tumor cell dormancy
Roger R. Gomis, Sylwia Gawrzak
Volume 11, Issue 1, January 2017

Circulating and disseminated tumor cells: harbingers or initiators of metastasis?
Arko Dasgupta, Andrea R. Lim, Cyrus M. Ghajar
Volume 11, Issue 1, January 2017

Epithelial–mesenchymal transition in tumor metastasis
Kay T. Yeung, Jing Yang
Volume 11, Issue 1, January 2017

Modes of invasion during tumour dissemination
Pahini Pandya, Jose L. Orgaz, Victoria Sanz‐Moreno
Volume 11, Issue 1, January 2017


Dysregulation of histone methyltransferases in breast cancer – Opportunities for new targeted therapies?
Ewa M. Michalak and Jane E. Visvader
Volume 10, Issue 10, December 2016

Metastatic breast cancer: The Odyssey of personalization
A. Sonnenblick, N. Ponde and M. Piccart
Volume 10, Issue 8, October 2016


Hepatocellular carcinoma: Where there is unmet need
Manojkumar Bupathi, Ahmed Kaseb, Funda Meric-Bernstam and Aung Naing
Volume 9, Issue 8, October 2015

Integrative analysis of cancer imaging readouts by networks
Marco Dominietto, Nicholas Tsinoremas and Enrico Capobianco
Volume 9, Issue 1, January 2015


Molecular pathology – The value of an integrative approach
Manuel Salto-Tellez, Jacqueline A. James and Peter W. Hamilton
Volume 8, Issue 7, October 2014

Standardized decision support in next generation sequencing reports of somatic cancer variants
Rodrigo Dienstmann, Fei Dong, Darrell Borger, Dora Dias-Santagata, Leif W. Ellisen, Long P. Le and A. John Iafrate
Volume 8, Issue 5, July 2014

Chromosome instability and carcinogenesis: Insights from murine models of human pancreatic cancer associated with BRCA2 inactivation
Liam D. Cassidy, Siong-Seng Liau and Ashok R. Venkitaraman
Volume 8, Issue 2, March 2014


Translating next generation sequencing to practice: Opportunities and necessary steps
Sitharthan Kamalakaran, Vinay Varadan, Angel Janevski, Nilanjana Banerjee, David Tuck, W. Richard McCombie, Nevenka Dimitrova and Lyndsay N. Harris
Volume 7, Issue 4, August 2013

Progression from ductal carcinoma in situ to invasive breast cancer: Revisited
Catherine F. Cowell, Britta Weigelt, Rita A. Sakr, Charlotte K. Y. Ng, James Hicks, Tari A. King and Jorge S. Reis-Filho
Volume 7, Issue 4, August 2013

Meeting the global demands of epidemiologic transition — The indispensable role of cancer prevention
Silvia Franceschi and Christopher P. Wild
Volume 7, Issue 1, February 2013

Somatic evolution of head and neck cancer — Biological robustness and latent vulnerability
Muneyuki Masuda, Satoshi Toh, Takahiro Wakasaki, Masumi Suzui and Andrew K. Joe
Volume 7, Issue 1, February 2013


Maintenance of genomic integrity after DNA double strand breaks in the human prostate and seminal vesicle epithelium: The best and the worst
Sari Jaamaa and Marikki Laiho
Volume 6, Issue 5, October 2012

Inhibition of NEDD8-conjugation pathway by novel molecules: Potential approaches to anticancer therapy
Tomoaki Tanaka, Tatsuya Nakatani and Tetsu Kamitani
Volume 6, Issue 3, June 2012

Exploitation of the propulsive force of chemotherapy for improving the response to cancer immunotherapy
Enrico Proietti, Federica Moschella, Imerio Capone and Filippo Belardelli
Volume 6, Issue 1, February 2012

Drug development to overcome resistance to EGFR inhibitors in lung and colorectal cancer
Rodrigo Dienstmann, Sara De Dosso, Enriqueta Felip and Josep Tabernero
Volume 6, Issue 1, February 2012

Systems pathology: A critical review
Jose Costa
Volume 6, Issue 1, February 2012


Molecular-targeted nanotherapies in cancer: Enabling treatment specificity
Elvin Blanco, Angela Hsiao, Guillermo U. Ruiz-Esparza, Matthew G. Landry, Funda Meric-Bernstam and Mauro Ferrari
Volume 5, Issue 6, December 2011

Non-coding RNAs in cancer initiation and progression and as novel biomarkers
S. Patrick Nana-Sinkam and Carlo M. Croce
Volume 5, Issue 6, December 2011

Metabolic effects of signal transduction inhibition in cancer assessed by magnetic resonance spectroscopy
Siver Andreas Moestue, Olav Engebraaten and Ingrid Susann Gribbestad
Volume 5, Issue 3, June 2011

Deconstructing the molecular portraits of breast cancer
Aleix Prat and Charles M. Perou
Volume 5, Issue 1, February 2011


Cytogenomics of cancers: From chromosome to sequence
Alain Bernheim
Volume 4, Issue 4, August 2010

Epidermal growth factor receptor mutation and diverse tumors: Case report and concise literature review
Lakshmi Chintala and Razelle Kurzrock
Volume 4, Issue 4, August 2010

Glycan gene expression signatures in normal and malignant breast tissue; possible role in diagnosis and progression
Ivan O. Potapenko, Vilde D. Haakensen, Torben Luders, Aslaug Helland, Ida Bukholm, Therese Sorlie, Vessela N. Kristensen, Ole C. Lingjaerde and Anne-Lise Borresen-Dale
Volume 4, Issue 2, April 2010

Targeted Therapies: The Rare Cancer Paradigm
Marco A. Pierotti, Tiziana Negri, Elena Tamborini, Federica Perrone, Sabrina Pricl and Silvana Pilotti
Volume 4, Issue 1, February 2010


Immunotherapy in the landscape of new targeted treatments for non-small cell lung cancer
Catherine Gerard and Channa Debruyne
Volume 3, Issue 5-6, October 2009

The role of protein synthesis in cell cycling and cancer
Shai White-Gilbertson, David T. Kurtz and Christina Voelkel-Johnson
Volume 3, Issue 5-6, October 2009

Review on early technology assessments of nanotechnologies in oncology
Valesca P. Retel, Marjan J. M. Hummel and Wim H. van Harten
Volume 3, Issue 5-6, October 2009

Biomarkers in oncology drug development
Darren R. Hodgson, Robin D. Whittaker, Athula Herath, Dereck Amakye and Glen Clack
Volume 3, Issue 1, February 2009

Targeted proteomic strategy for clinical biomarker discovery
Ralph Schiess, Bernd Wollscheid and Ruedi Aebersold
Volume 3, Issue 1, February 2009


Biobanking for better healthcare
Peter H. J. Riegman, Manuel M. Morente, Fay Betsou, Pasquale de Blasio and the Marble Arch International Working Group on Biobanking for Biomedi
Volume 2, Issue 3, October 2008

Innovations, challenges and future prospects of oncoproteomics
Kewal K. Jain
Volume 2, Issue 2, August 2008

Imaging and cancer: A review
Leonard Fass
Volume 2, Issue 2, August 2008

Epigenetics and cancer, 2nd IARC meeting, Lyon, France, 6 and 7 December 2007
Marie-Pierre Lambert, Zdenko Herceg
Volume 2, Issue 1, June 2008

Molecular aspects of tumour hypoxia
Saskia E. Rademakers, Paul N. Span, Johannes H. A. M. Kaanders, Fred C. G. J. Sweep, Albert J. van der Kogel and Johan Bussink
Volume 2, Issue 1, June 2008

High throughput molecular diagnostics in bladder cancer — on the brink of clinical utility
Karsten Zieger
Volume 1, Issue 4, April 2008

Human cutaneous melanoma; a review of NRAS and BRAF mutation frequencies in relation to histogenetic subclass and body site
Anton Platz, Suzanne Egyhazi, Ulrik Ringborg and Johan Hansson
Volume 1, Issue 4, April 2008


New insights into the functional mechanisms and clinical applications of the kallikrein-related peptidase family
Nashmil Emami and Eleftherios P. Diamandis
Volume 1, Issue 3, December 2007

Cancer proteomics by quantitative shotgun proteomics
Emily I. Chen and John R. Yatess III
Volume 1, Issue 2, September 2007

Identifying estrogen receptor target genes
Willem-Jan Welboren, Henk G. Stunnenberg, Fred C. G. J. Sweep and Paul N. Span
Volume 1, Issue 2, September 2007

The role of histone deacetylases (HDACs) in human cancer
Santiago Ropero and Manel Esteller
Volume 1, Issue 1, June 2007

Genetic and epigenetic alterations as biomarkers for cancer detection, diagnosis and prognosis
Zdenko Herceg and Pierre Hainaut
Volume 1, Issue 1, June 2007

Cancer therapeutic antibodies come of age: Targeting minimal residual disease
Tsipi Ben-Kasus, Bilha Schechter, Michael Sela and Yosef Yarden
Volume 1, Issue 1, June 2007


From January 1, 2017 Molecular Oncology is published by FEBS Press and Wiley

Molecular Oncology has become fully Open Access, allowing everyone to read the journal irrespective of speciality, host institution or location. All articles are published under the Creative Commons Attribution License (CC BY) to meet funders’ requirements worldwide.


Citation Metrics

  • 2016 2-Year Impact Factor: 5.314
  • 2016 5-Year Impact Factor: 5.957
  • 2016 CiteScore: 5.25

Editorial Board

Editor-in-Chief Julio Celis

Senior Associate Editors Anne-Lise Børresen-Dale and  Ulrik Ringborg 

Managing Editor Jose Moreira

Future Events in Oncology

30-31 January, 2018, London, United Kingdom
01-03 February, 2018, Amsterdam, Netherlands
05-07 February, 2018, Milan, Italy
14-16 February, 2018, Cape Town, South Africa
01-02 March, 2018, Valencia, Spain
05-07 March, 2018, Paris, France
12-14 March, 2018, Oxford, United Kingdom
19-21 March, 2018, Berlin, Germany
21-23 March, 2018, Barcelona, Spain
23-29 March, 2018, Barcelona, Spain
11-14 April, 2018, Geneva, Switzerland
20-24 April, 2018, Barcelona, Spain
27-29 April, 2018, Lugano, Switzerland
21-26 May, 2018, Ohio, USA
04-06 June, 2018, Amsterdam, Netherlands
16-22 June, 2018, Zeist, Netherlands
22-23 June, 2018, TBC, Dominican Republic